Abstract
Modern diagnostics is in general based on molecular biology methods. Nowadays sequencing-based methods, especially whole genome sequencing, are becoming increasingly important. Implementation of such methods into routine diagnostic of highly dangerous pathogens, like Bacillus anthracis, Francisella tularensis, Yersinia pestis, Ebola virus, MERS, Lassa virus etc. would be very helpful. The best diagnostic strategy would be the metagenomic sequencing directly from the clinical sample. Implementation of majority of currently available WGS platforms inside the BSL-3 or 4 laboratory is impractical because of the size of the equipment and time consuming wet lab part (e.g. library preparation). Nowadays there is a possibility to implement pocket size MinION - real time whole genome sequencer into BSL-3 and 4 laboratory for rapid and precise diagnostic purposes.
Keywords: Whole genome sequencing, molecular diagnostics, BSL-3, BSL-4
Manuscript
Modern molecular diagnostics
Diagnostics schemes of different diseases and pathogens changed a lot during last decades. At present, commonly available diagnostic tests are often based on molecular biology techniques, quite often without any preculture step. Such culture-free diagnostic is very valuable especially in the context of highly pathogenic bacteria like e.g. Bacillus anthracis, Francisella tularensis, Yersinia pestis [1–5] or viruses like e.g. Ebola virus, MERS, SARS, Lassa virus etc. [6–9], because every culture step can be difficult and, what is even more important, dangerous. Most of the molecular diagnostics is based on PCR methods, both regular and real-time version. There are also other advantages of such diagnostic strategy. The result can be rapidly obtained when compared with the classical, culture based techniques (bacterial culture takes at least one day, whereas result of PCR reaction can be obtained within few hours). In most cases molecular methods have also much higher sensitivity and specificity. But even these methods seems not to be ideal and sometimes their high sensitivity can result in occurrence of false positive results. This is because of the fact, that all PCR methods are based only on the specificity (but not identity) of only short oligonucleotide fragments (and more or less accurate distance between these primers). In this case contamination with high amount of different nucleic acids that can be present inside the probe (e.g. patient DNA/mRNA) may introduce additional noise to the test. Because of that, for example, during complex molecular diagnostics of suspected Ebola case directly from the clinical sample it is recommended to confirm every positive result with another molecular test focused on different genetic target or by sequencing [10].
Advantages of introducing of whole genome sequencing into diagnostic shame
Modern diagnostics is changing day by day and methods based on whole genome sequencing analysis (WGS) are of increasing importance nowadays [11]. WGS sequencing techniques, like e.g. most prevalent Illumina, IonTorrent, PacBio, Nanopore and many other give the possibility of rapid perform thousands of reads of DNA sequence and because of that are able to generate sequences more or less covering whole microbial genome (comparison of most prevalent sequencing platforms in table 1). There are some Institutes, where these methods are already implemented into routine diagnostic, and the WGS approaches often are replacing classical methods [12, 13]. The reason for this is that WGS analysis could give much more information than any other molecular and classical method. For example, in a single PCR it is possible to analyse only the occurrence of two short sequences homologous to used primers, within relatively short distance. By contrast, WGS based analysis could yield precise information about every sequence in the genome and allows to perform many accurate comparisons [14] (analytical strategies are shown in the figure 1). Such information, especially during an ongoing public health threat, where accurate and timely information is extremely important, whole genome analysis can provide near real-time insights into pathogen’s origin, transmission dynamics, mechanisms of adaptation, resistance traits and evolution. That is because of the fact, that rapidly performed WGS analysis will show every changes in the pathogen genome from single point mutations to acquisition of new genes, plasmids etc. Of course it has to be taken into account that the accuracy of different sequencing techniques can vary and different techniques can give slightly different results, especially in the context of point mutations (for example because of the error rate). Additionally whole genome metagenomics analysis of clinical samples can identify many different pathogens in a single analysis. For example, Gire et al. [15] during their analysis of 35 samples from suspected Ebola virus disease (EVD) cases (but tested negative for Ebola virus) identified other known pathogens like Lassa virus, HIV-1, enterovirus A and malaria parasites. Metagenomics sequencing was useful also in the case of a novel filovirus that caused an outbreak in Uganda in 2007 [16]. The advantages of metagenomic sequencing include also its relative speed, the ability to detect non-culturable pathogens and, as it was shown, detect of new pathogens (what is impossible using other techniques). There are also some problems with such metagenomic sequencing for diagnostic purposes. Because of the fact that this is still quite new methodology there are no consistent standards what constitutes identification of the pathogen in the sample, how many positive reads are necessary for identification of a true positive result. Because of that it is hard to estimate the efficiency of the method, but it looks that it should be even more sensitive than RT-PCR (which is 1-2 orders of magnitude more sensitive than classical PCR) and the efficiency can be different for different pathogens. The situation seems to be easier with the positive results – detection of even one pathogen specific read in a clinical sample, that are not found in control samples is likely to be interpreted as a positive result. However, for negative results important is the knowledge about limits of detection (LoD). There are many analysis showing that LoD level can vary between different sequencing platforms, variation in the extraction techniques or used sample preparation kit. All these variables can affect the composition of sequence reads [17, 18, 19]. For example Cheval et al. [20] compared Roche-454 pyrosequencing with Illumina in a detection of eleven different viruses with known concentrations in cerebrospinal fluid and plasma samples. In this study it was shown that Illumina gives higher output that resulted in more sensitive detection of the tested viruses per run. Also Frey et al. [21] were compared three WGS platforms: Roche-454 Titanium, Illumina MiSeq and Ion Torrent for metagenomics using among others Dengue virus and Bacillus anthracis. They found out that Roche-454 Titanium platform produced longer reads, whereas Illumina MiSeq platform produced consistently greater depth and breadth of coverage while the Ion Torrent has higher speed of sequencing.
Table 1.
Comparison of efficiency of most important WGS platforms.
Sequencing platform | Single read length | Amount of data per flow-cell | Run types |
---|---|---|---|
Sanger sequencing | 800-1500 | – | – |
Roche 454 | 300–500 | 0, 4–0, 7 Mb | Single end |
Illumina MiSeq | 100–140 | 0, 3–15 Gb | Single and paired end |
Illumina HiSeq | 150-250 | 125–600 Gb | Single and paired end |
IonTorrent | 200-400 | 1, 5–2 Gb | Single end |
PacBio | 10 000–20 000 | 5–8 Gb | Single end |
Nanopore - MinION | 10 000–300 000 | 5–10 Gb | 1D and 2D reads |
Figure 1.
WGS strategies and possible analyses.
To increase the amount of pathogen DNA (or RNA) in a clinical sample it is also possible to amplify it by the PCR (or RT-PCR) reaction (preferably multiplex PCR) before sequencing. Such multiplex PCR enrichment protocol was proposed by Quick et al. [22] for viruses like e.g. Zika detection. The selectivity of such preamplificatin step and described previously limitation of PCR/RT-PCR can add some additional bias into the analysis.
In this context, would it be possible, and reasonable to easily implement such analysis into BSL-3 or BSL-4 lab, for the purposes of diagnosis of most dangerous pathogens, both bacterial and viral.
WGS methods in the BLS-3 and 4 laboratories environment
BSL-3 and BSL-4 are very sophisticated and specialised environments, with multiple restrictions concerning manipulations of the examined material, safety procedures and usage of laboratory equipment (for review of all important rules and recommendations of designing, constructing and operating procedures in different classes laboratories see WHO “Laboratory biosafety manual” [23] and CDC “Biosafety in Microbiological and Biomedical Laboratories” [24]). This class of laboratories is designed for working with highly dangerous pathogens that pose a high individual risk of aerosol-transmitted laboratory infections and life-threatening disease. Assignment of the pathogen to the appropriate safety class (from class 2 to 4) is defined in relevant local regulations [25]. There are also some differences in the pathogen classification due to differences in the type of research conducted. For example, diagnostics of potential Ebola virus disease cases should be performed in the BSL-3 class laboratory. But scientific researches of Ebola viruses should be rather performed in the BSL-4 class laboratory because of the need of work with the larger inoculum of the pathogen.
BSL-3 and 4 laboratories have highly limited access through few locks. Inside this kind of laboratory all manipulations of potential infectious materials within the laboratory must be in appropriate class II or III biosafety cabinets (BSC). All personnel that is working inside the laboratory have to wear special protective, multilayer clothes, masks, gloves and/or special suits. Despite of these difficulties every procedure has to be done carefully, usually by two people (one person is working inside the BSC and another person is assisting). That makes working inside such laboratory very uncomfortable. Because of that it is nearly impossible to perform all the manipulations directly like in BSL-1 or BSL-2 laboratory. Additionally, every laboratory equipment must be routinely decontaminated, especially after every potential contamination or before removal from the laboratory. Because of these restrictions only necessary equipment should be stored inside the laboratory. This also limits the use of large, sophisticated (and because of that quite delicate) equipment like e.g. most NGS sequencers.
Due to all these limitations, inside the BSL-3 or 4 class laboratory only initial pathogen inactivation or nucleic acids isolation is usually carried out [26, 27, 28]. All further analyses can be conducted on inactivated nucleic acid samples in standard molecular laboratory, under normal operation procedures and standards. Such a course of action should be applied also during preparation of NGS analyses. So nowadays implementation of most of such techniques to diagnostic schemes of class 3 and 4 pathogens could be similar to those already adopted for other pathogens. Of course taking the sample out of the BSL-3 or BSL-4 laboratory can be dangerous. First of all not all potential pathogens present in the sample can be completely inactivated (because of e.g. occurrence of hardly damage spores or because of simply laboratory mistakes). Additionally, decontamination of the sample should be performed as precisely as possible, but on the other hand this process can damage the sample. Another problem with taking the sample outside is the time. Because of the multiple protective clothes and locks it can take additional 15-30 minutes. That is why it sometimes it would be better to have the possibility to perform as much analysis as possible inside the BSL-3 or BSL-4 laboratory. Short compilation of different steps performed inside and outside the BSL-3 or BSL-4 laboratory is shown in the figure 2.
Figure 2.
Compilation of different analytical steps performed inside and outside the BSL-3 or BSL-4 laboratory.
There are also some disadvantages of implementation of WGS analysis for routine diagnostics of class 3 and 4 pathogens. First of all such diagnostics usually should be as fast as possible. The time needed for whole protocol (isolation of good quality DNA, constructing the library and sequencing itself) can be estimate for at least 2-3 days [11]. Analysis of RNA viruses, like Ebola or Lassa viruses would last even longer because of the need of cDNA synthesis [15, 29]. Another weakness, but more debatable one, of this kind of analysis is its unit cost. First of all the cost of the sequencing platform and every other necessary equipment is still high. Additionally, cost of single analysis can be much lower than 100 Euro, but it usually requires a large number of analysis for maximum flow cell filling. Diagnostics of most dangerous pathogens is not required quite often, what it is good from the public health reasons, but unfortunately can substantially rise the unit price. In a larger scientific centres, with WGS techniques implemented for routine analysis, it should not be a problem to sequence already prepared probe on one flow cell with other samples to lower the sequencing costs.
Nanopore sequencing technology in the BSL-3 and 4 laboratory
Different scheme of work organization in BSL-3 and 4 laboratory, in the context of WGS analysis, can be implement with Oxford Nanopore Technologies sequencing technology, especially with the MinION sequencer. This sequencing platform presents completely different approach to sequencing technology. In fact all other technologies are based on some kind of DNA modification and/or synthesis [30]. Whereas the mechanism of Nanopore sequencing is based on translocation of single nucleic acid strand through a special pore protein located in an electrically resistant polymer membrane [31]. The current is changed as the different bases pass through the pore in different combinations (for more precise information see www.nanoporetech.com). As a result, Nanopore DNA sequencing can be aligned to the simple reading of sequence of nucleotides in the nucleic acid strand.
This sequencing strategy gives multiple advantages. First of all it can generate extremely long reads (usually about 10-20 kb, but it is also possible to generate much longer reads, even about 300 kb). Also preparing of sequencing library can be quite easy and fast, because it can be limited only to ligation of specific adaptors. Usually two types of adaptors are used at the same time – standard double strand and hairpin shape (especially for 2 D reads). The adaptors provide the mechanism of enrichment of the DNA fragments on the membrane within the flow cell, increasing the efficiency of the sequencing. Standard library preparation would take about 2–4 hours but there are many protocols where it can be reduced to about 20-30 min [32, 33]. But using equipment called Voltrax® it can be theoretically shortened to about 10 minutes [34]. That makes it possible to easily prepare the library everywhere, also inside the class 2 or 3 biosafety cabinet inside the BSL-3 or 4 laboratory (see Figure 3).
Figure 3.
Analysis with MinION inside the class 2 BSC.
Another advantages of Nanopore technology is the possibility to create extremely small sequencers. MinION measures 9.5 × 3.2 × 1.6 cm, draws its power from a laptop or tablet via a Universal Serial Bus connection, with a total mass of less than 100 grams so it is smaller than a smartphone. For working it have to be plug into a PC or laptop by the USB cable. That made it also possible to take it into International Space Station [35, 36] or in the Antarctic Dry Valleys [37] so it is also possible to implement it also in the BSL-3 and 4 laboratory environment and prepare all the sequencing steps inside the BSC. It would be also possible to use MinION in the field laboratory e.g. in Africa, that is in areas directly exposed to possible outbreak of e.g. Ebola virus [38, 39]. Moreover, the overall price of the sequencing chamber is relatively low, thus can be considered disposable in BSL3 or BSL4 applications. The only thing that would get contaminated and that would have to be get out from the BSC is the flow cell. One flow cell should suffice for few more sequencing runs. Between them the flow cell can be easily wash with two simply reagents. When the flow cell will worn out it can be moved of the sequencer and throw away after sterilisation.
Important feature of Nanopore technology is that sequencing data are streamed into the computer in a real time and can be analysed in the same way [40]. The standard run can be conducted for 48 hours, and in this time is should generate around 5–10 Gb of DNA sequence data. But for the rapid diagnostic it would be better to perform real time analysis of obtained data looking for these sequences that would be homologous to known pathogens. Calculating that using newest “R9” chemistries and flow cell it is possible to sequence at a speed of around 250 bases per second per nanopore (MinION flow cell has 512 nanopores on the membrane surface) it will give around 76 million bases completely read after first 10 minutes. In such big amount of data it should be possible to find sequences matching to pathogens of interest.
In most sequencing technologies more problematic would be the diagnosis and sequencing of the RNA viruses (like e.g. viruses Ebola, Marburg or Lassa) because of the need of cDNA synthesis. Simple “reading” of non-modified nucleic acid on Nanopore sequencers makes it also possible to sequence and analyse the RNA directly, without cDNA synthesis step [41].
Completely different issue is the analysis of WGS data, and this is also a problem with the data produced by Oxford Nanopore sequencers. There are some bioinformatics tools, focused on WGS data and available on-line (like, e.g. Galaxy Tools or CGE tools)[42, 43], but they are usually unable to analyse raw files from Nanopore (files in the fast5 that use the HDF format instead of standard fastq file. Fastq files are inside the fast5 files and could be further extracted). Another analytical strategy assumes use of bioinformatics software like e.g. CLC Genomics Workbench, Lasergene package or BioNumeris, but none of these programmes analyse files in fast5 format (maybe it will be possible in the future). The greatest analytical possibilities are available by using Unix system tools and the command line, but using of these bioinformatics algorithms requires advanced bioinformatics skills. In this situation there is a possibility to use e.g. Canu genome assembler. There is also a possibility to use available web-based services for assembly the Nanopore reads, usually based on Canu assembler, like e.g. NanOnline (http://minion.cent.uw.edu.pl/) [44, 45]. But for rapid diagnostic of highly dangerous pathogens most useful would be the algorithm to perform real time comparison of the data obtained during the sequencing process to the database of known sequences, especially those that are pathogen specific. However bioinformatics algorithms and scripts are developing very dynamically and detailed description of these topic exceeds the framework of this publication.
Conclusions
At present, molecular biology techniques, especially those referring to DNA sequencing, are developed rapidly. Because of this fact it is really hard to foresee the future of diagnostics. Classical PCR reaction, developed in the year 1983 is still in widespread use and, despite many changes and modifications, it is based on the same methodological foundations [46]. It seems obvious, also for many international experts [11, 47], that the main direction in a near future diagnostic will be associated with any whole genome sequencing methods, but it is really hard to foresee on which technology, because of the speed of technology development. Sanger sequencing method, developed in the year 1977 is also still in use [48], but nowadays it is widely supplanted by newer, Next Generation Sequencing methods. However, currently the life span of these modern methods is much shorter. For example pyrosequencing based sequencing technology was considered modern a few years ago [49]. Now it is widely replaced by more popular Illumina technology [50]. But even Illumina can also be easily supplanted by newer techniques, for example those that are able to produce much longer reads. And that is why more and more laboratories are implementing e.g. more modern PacBio technology [51]. That is also the problem with prediction, whether Nanopore sequencing technology [52], that can be considered as a real revolution in the field of nucleic acids sequencing, will constitute a basic diagnostic technique in the future. Maybe the existing problems with the throughput (maybe solved by introducing of bigger equipment like PromethION), quite high error rate (but lower in each new generation of the flow cell and chemistry) or lack of easily accessible and “microbiologist friendly” software will make the technology soon replaced by another one. Nevertheless, nowadays such WGS analysis looks like the best choice for rapid diagnostics of highly dangerous pathogens. Further development of these techniques would make it possible, to implement them into BSL-3 and 4 laboratory, what will reduce some analytical steps, will solve the problems with decontamination of the sample and will make it possible to receive the results much faster than it is now.
Key Points
Whole genome sequencing methods are becoming increasingly important in the routine diagnostics.
WGS platforms can be used for the purposes of diagnostics of high dangerous bacteria and viruses, especially for the metagenomics analysis.
Most of the WGS platforms shouldn t be implemented inside the BSL-3 or 4 laboratory.
Oxford Nanopore MinION device is a sequencer that can be easily implement into the BSL-3 or 4 laboratory.
Funding
This work was supported by National Science Centre in Poland [grant number 2015/17/N/NZ6/03517]
Tomasz Wołkowicz is a microbiologist in National Institute of Public Health – NIH in Poland. He is focused on clinical microbiology and molecular diagnostic. He is interested in whole genome sequencing techniques.
References
- 1. Johansson A, Ibrahim A, Gorangsson I, et al. Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis. J. Clin. Microbiol 2000; 38:4180–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Tomaso H, Scholz HC, Naubauer H, et al. Real-time PCR using hybridization probes for rapid and specific identification of Francisella tularensis subspecies tularensis. Mol. Cell. Probes 2007; 21:12–6. [DOI] [PubMed] [Google Scholar]
- 3. Jackson PJ, Hugh-Jones ME, Adair DM, et al. PCR analysis of tissue samples from the 1979 Svierdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims. Proc. Natl. Acad Sci. USA 1998; 95: (3) 1224–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Gierczyński R, Zasada AA, Raddadi N, et al. Specific Bacillus anthracis identification by a plcR-targeted restriction site insertion-PCR (RSI-PCR) assay. FEMS Microbiol. Lett 2007; 272:55–9. [DOI] [PubMed] [Google Scholar]
- 5. Zhou D, Han Y, Dai E, et al. Identification of signature genes for rapid and specific characterization of Yersinia pestis. Microbiol. Immunol 2004; 48:263–9. [DOI] [PubMed] [Google Scholar]
- 6. Demby AH, Chamberlain J, Brown DW, Clegg CS.. Early diagnosis of Lassa fever by reverse transcription-PCR. Journal of Clinical Microbiology 1994; 32:(12) 2898–903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Drosten C, Göttig S, Schilling S, et al. Rapid Detection and Quantification of RNA of Ebola and Marburg Viruses, Lassa Virus, Crimean-Congo Hemorrhagic Fever Virus, Rift Valley Fever Virus, Dengue Virus, and Yellow Fever Virus by Real-Time Reverse Transcription-PCR. Journal of Clinical Microbiology 2002; 40: (7) 2323–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Sanchez A, Ksiazek TG, Rollin PE, et al. Detection and molecular characterization of Ebola Viruses Causing Disease in Human and Nonhuman Primates. J Infect Dis 1999;179: (s1) S164–9. [DOI] [PubMed] [Google Scholar]
- 9. Panning M, Laue T, Olschlager S, et al. Diagnostic Reverse-Transcription Polymerase Chain Reaction kit for Filoviruses based on the strain collections of all European Biosafety Level 4 laboratories. J Infect Dis 2007;196: (s2) S199–204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. European Centre for Disease Prevention and Control. Algorithm for laboratory diagnosis of Ebola virus disease http://www.ecdc.europa.eu/en/healthtopics/ebola_marburg_fevers/algorithm-evd-diagnosis/Documents/EVD-lab-diagnosis-algorithm.pdf.
- 11. European Centre for Disease Prevention and Control. Expert Opinion on the introduction of next-generation typing methods for food- and waterborne diseases in the EU and EEA. Stockholm: ECDC; 2015. [Google Scholar]
- 12. Ashton PM, Nair S, Peters TM, et al. Identification of Salmonella for public health surveillance using whole genome sequencing. Izarzugaza J, Ed. PeerJ 2016; 4:e1752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Cummings CA, Bormann Chung CA, Fang R, et al. Accurate, rapid and high-throughput detection of strain-specific polymorphisms in Bacillus anthracis and Yersinia pestis by next-generation sequencing. Investigative Genetics 2010;1: (1) 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Girault G, Blouin Y, Vergnaud G, Derzelle S.. High-throughput sequencing of Bacillus anthracis in France: investigating genome diversity and population structure using whole-genome SNP discovery. BMC Genomics 2014;15: (1) 288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science (New York, NY) 2014; 345: (6202) 1369–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Towner JS, Sealy TK, Khristova ML, et al. Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda. Basler CF, ed. PLoS Pathogens 2008; 4: (11) e1000212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Delmont TO, Prestat E, Keegan KP, et al. Structure, fluctuation and magnitude of a natural grassland soil metagenome. The ISME Journal 2012; 6: (9) 1677–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Henderson G, Cox F, Kittelmann S, et al. Effect of DNA Extraction Methods and Sampling Techniques on the Apparent Structure of Cow and Sheep Rumen Microbial Communities. Bertilsson S, ed. PLoS ONE 2013; 8: (9) e74787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Moore RA, Warren RL, Freeman JD, et al. The Sensitivity of Massively Parallel Sequencing for Detecting Candidate Infectious Agents Associated with Human Tissue. Jordan IK, ed. PLoS ONE 2011; 6: (5) e19838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Cheval J, Sauvage V, Frangeul L, et al. Evaluation of High-Throughput Sequencing for Identifying Known and Unknown Viruses in Biological Samples. Journal of Clinical Microbiology 2011; 49: (9) 3268–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Frey KG, Herrera-Galeano JE, Redden CL, et al. Comparison of three next-generation sequencing platforms for metagenomic sequencing and identification of pathogens in blood. BMC Genomics 2014;15: (1) 96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Quick J, Grubaugh ND, Pullan ST, et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. bioRxiv 2017; 9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. World Health Organization. Laboratory biosafety manual. – 3rd edition Geneva; 2004. [PubMed] [Google Scholar]
- 24.Centers for Disease Control and Prevention; National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories. – 5th edition; 2009.
- 25. Directive 2000/54/EC of the European Parliament and of the Council of 18 September2000 on the protection of workers from risks related to exposure to biological agents at work. Official Journal of the European Communities 2000; I.262/21 [Google Scholar]
- 26. Gunther S, Asper M, Roser C, et al. Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro. Antiviral Res 2004; 63: (3) 209–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Grard G, Biek R, Muyembe Tamfum J-J, et al. Emergence of Divergent Zaire Ebola Virus Strains in Democratic Republic of the Congo in 2007 and 2008. The Journal of Infectious Diseases 2011;204 suppl 3S776–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Kobinger GP, Leung A, Neufeld J, et al. Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J Infect Dis 2011; 204: (2) 200–8. [DOI] [PubMed] [Google Scholar]
- 29. Matranga CB, Andersen KG, Winnicki S, et al. Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples. Genome Biology 2014; 15: (11) 519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Pareek CS, Smoczynski R, Tretyn A.. Sequencing technologies and genome sequencing. Journal of Applied Genetics 2011; 52: (4) 413–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Feng Y, Zhang Y, Ying C, et al. Nanopore-based Fourth-generation DNA Sequencing Technology. Genomics, Proteomics & Bioinformatics 2015; 13: (1) 4–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Oxford Nanopore Technologies website - protocols: https://nanoporetech.com/sites/default/files/s3/2016-07/libprepv1.pdf.
- 33. Oxford Nanopore Technologies website - protocols: https://nanoporetech.com/publications/strand-specific-preparation-full-length-and-whole-viral-genome-1d-and-2d-cdna.
- 34. Oxford Nanopore Technologies website - protocols: https://nanoporetech.com/publications/2016/05/26/voltrax-rapid-programmable-portable-disposable-sample-processor.
- 35. Castro-Wallace SL, Chiu CY, John KK, et al. Nanopore DNA Sequencing and Genome Assembly on the International Space Station. bioRxiv 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. McIntyre ABR, Rizzardi L, Yu AM, et al. Nanopore sequencing in microgravity. Npj Microgravity 2016; 2: (1). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Johnson SS, Zaikova E, Goerlitz DS, et al. Real-Time DNA Sequencing in the Antarctic Dry Valleys Using the Oxford Nanopore Sequencer. Journal of Biomolecular Techniques : JBT 2017; 28: (1) 2–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Hoenen T. Sequencing of Ebola Virus Genomes Using Nanopore Technology. Bio-protocol 2016; 6: (21) e1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Coltart CEM, Lindsey B, Ghinai I, et al. The Ebola outbreak, 2013–2016: old lessons for new epidemics. Philosophical Transactions of the Royal Society B: Biological Sciences 2017; 372: (1721) 20160297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Cao MD, Nguyen SH, Ganesamoorthy D, et al. Scaffolding and completing genome assemblies in real-time with nanopore sequencing. Nature Communications 2017; 8:14515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Bolisetty MT, Rajadinakaran G, Graveley BR.. Determining exon connectivity in complex mRNAs by nanopore sequencing. Genome Biology 2015; 16:204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Larsen MV, Cosentino S, Lukjancenko O, et al. Benchmarking of Methods for Genomic Taxonomy. Land GA, ed. Journal of Clinical Microbiology 2014; 52: (5) 1529–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Giardine B, Riemer C, Hardison RC, et al. Galaxy: A platform for interactive large-scale genome analysis. Genome Research 2005; 15: (10) 1451–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Mazzocco G, Wróblewski P, Lermo M, et al. NanOnline: web-based service for MinION Assembly. Poster at second Nanopore London Calling conference.
- 45. Judge K, Hunt M, Reuter S, et al. Comparison of bacterial genome assembly software for MinION data and their applicability to medical microbiology. Microbial Genomics 2016; 2: (9) e000085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Mullis K, Faloona F, Scharf S, et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol 1986;51: (0) 263–73. [DOI] [PubMed] [Google Scholar]
- 47. Nadon C, Van Walle I, Gerner-Smidt P, et al. PulseNet International: Vision for the implementation of whole genome sequencing (WGS) for global food-borne disease surveillance. Eurosurveillance 2017; 22: (23) 30544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Sanger F, Nicklen S, Coulson AR.. DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences of the United States of America 1977; 74: (12) 5463–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Ronaghi M, Uhlén M, Nyrén P.. A sequencing method based on real-time pyrophosphate. Science 1998; 281: (5375) 363- 365. [DOI] [PubMed] [Google Scholar]
- 50. Canard B, Sarfati RS.. DNA polymerase fluorescent substrates with reversible 3'-tags. Gene 1994; 148: (1) 1–6. [DOI] [PubMed] [Google Scholar]
- 51. Eid J, Fehr A, Gray J, et al. Real-time DNA sequencing from single polymerase molecules. Science 2009; 323: (5910) 133–8. [DOI] [PubMed] [Google Scholar]
- 52. Kasianowicz JJ, Brandin E, Branton D, Deamer DW.. Characterization of individual polynucleotide molecules using a membrane channel. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: (24) 13770–3. [DOI] [PMC free article] [PubMed] [Google Scholar]